Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N et al (2019) Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open 5(2)
Heijstek MW, Ott De Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I et al (2011) EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 70(10):1704–12
Thiele F, Klein A, Windschall D, Hospach A, Foeldvari I, Minden K et al (2021) Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatol Int 41(4):751–762
Article PubMed PubMed Central Google Scholar
Cuadros E, Calzada-Hernández J, Clemente D, Martín S, Silveira L, Lirola-Cruz M et al (2022) Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening). Eur J Pediatr 181(6):2343–2354
Article PubMed PubMed Central Google Scholar
CEBM Medicine (2011) CfEB: CEBM levels of evidence 2011. http://www.cebm.net/index.aspx?o=1025. Accessed 4 Nov 2013
Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M et al (2017) American college of rheumatology/american association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care Res (Hoboken) 69(8):1111–1124
Zakaryan A, Ginosyan K (2020) Perioperative management of patients with ankylosing spondylitis undergoing spine surgery. Front Pharmacol 11(1017)
Ahmet A, Rowan-Legg A, Pancer L (2021) Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity. Paediatr Child Health 26(4):242–247
Article PubMed PubMed Central Google Scholar
Shulman DI, Palmert MR, Kemp SF (2007) Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 119:484–494
Amir H Hamrahian (2023) The management of the surgical patient taking glucocorticoids. Uptodate. Last updated: March, 2023
Clay M, Mazouyes A, Gilson M, Gaudin P, Baillet A (2016) Risk of postoperative infections and the discontinuation of TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis. Joint Bone Spine 83(6):701–705
Article CAS PubMed Google Scholar
Pieringer H, Danninger K, Tzaribachev N, Böhler N, Pohanka E, Herold M (2013) Patients with arthritis undergoing surgery: how should we manage tumour necrosis factor blocking agents perioperatively? -a systematic literature review. Yonsei Medical J 54:253–257
Scherrer CB, Mannion AF, Kyburz D, Vogt M, Kramers-De Quervain IA (2013) Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs. Arthritis Care Res 65(12):2032–2040
Molimard J, Pajot C, Olle P, Belot A, Quartier P, Uettwiller F et al (2021) Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice. Pediatr Rheumatol Online J 19(1):139
Article PubMed PubMed Central Google Scholar
Udaondo C, Núñez Cuadros E, Murias S, Remesal A, Alcobendas R, Guerrero C et al (2022) Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study. Front Pediatr 11(10):917731
Horneff G (2015) Biologic-associated infections in pediatric rheumatology. Curr Rheumatol Rep 17:66
Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG et al (2012) Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64(8):2773–2780
Article PubMed PubMed Central Google Scholar
Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfá E, Silva CA et al (2018) High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting. Mod Rheumatol 28(2):264–270
Nagy A, Mátrai P, Hegyi P, Alizadeh H, Bajor J, Czopf L et al (2019) The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis. Pediatr Rheumatol Online J 17(1):4
Cates M, Donati M, Gillet S, Ustianowski A, Galloway J (2018) Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy. Rheumatology (Oxford) 57(4):596–605
Article CAS PubMed Google Scholar
Cates M, Donati M, Gillet S, Ustianowski A, Galloway J (2018) Comment on: managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy. Rheumatology (Oxford) 57(4):768
Public Health England (2019) Updated guidelines on post exposure prophylaxis (PEP) for varicella/shingles June 2019. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/812526/PHE_PEP_VZIG_guidance_for_health_professionals.pdf
Committee on Infectious Diseases. American Academy of Pediatrics; Kimberlin DW, Brady MT, Jackson MA, Long SS. Varicella-Zoster virus infections. In: Red Book 2018. 31st Edition 869–883
Prober CG (1997) Acyclovir therapy in a steroid recipient with varicella. Pediatr Infect Dis J 16(11):1095–1096
Article CAS PubMed Google Scholar
Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ (1996) Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 22(2):341–347
Article CAS PubMed Google Scholar
Beutner K, Friedman D, Forszpaniak C, Andersen P, Wood M (1995) Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39(7):1546–1553
Article CAS PubMed PubMed Central Google Scholar
Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M et al (2016) Clinical course, and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Pediatr Rheumatol Online J 14(1):34
Article PubMed PubMed Central Google Scholar
Moreno-Pérez D, Andrés Martín A, Altet Gómez N, Baquero-Artigao F, Escribano Montaner A, Gómez-Paístrana Durán D et al (2010) Diagnosis of tuberculosis in paediatrics. An Pediatr (Barc) 72(4):283.e1–283.e14
Silva DR, Rabahi MF, Sant’Anna CC, da Silva-Junior JLR, Capone D, Bombarda S et al (2021) Diagnosis of tuberculosis: a consensus statement from the Brazilian Thoracic Association. J Brasil Pneumol 47(2):e20210054
Pillay T, Andronikou S, Zar HJ (2020) Chest imaging in paediatric pulmonary TB. Vol. 36, Paediatr Respir Rev 36:65–72
Nel M, Franckling-Smith Z, Pillay T, Andronikou S, Zar HJ (2022) Chest imaging for pulmonary TB—an update. Pathogens 11(2):161
Article PubMed PubMed Central Google Scholar
Hatherill M, Hawkridge T, Zar HJ, Whitelaw A, Tameris M, Workman L et al (2009) Induced sputum, or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch Dis Child 94(3):195–201
Article CAS PubMed Google Scholar
Nicol MP, Zar HJ (2020) Advances in the diagnosis of pulmonary tuberculosis in children. Paediatr Respir Rev 36:52–56
PubMed PubMed Central Google Scholar
Mellado Peña MJ, Santiago García B, Baquero-Artigao F, Moreno Pérez D, Piñeiro Pérez R, Méndez Echevarría A et al (2018) Tuberculosis treatment for children: an update. An Pediatr (Barc) 88(1):52.e1–52.e12
Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G et al (2015) Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev 14:503–9
Calzada-Hernández J, Anton-López J, Bou-Torrent R, Iglesias-Jiménez E, Ricart-Campos S, Martín de Carpi J et al (2015) Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study. Pediatr Rheumatol Online J 13(54)
Turkova A, Wills GH, Wobudeya E, Chabala C, Palmer M, Kinikar A et al (2022) Shorter treatment for nonsevere tuberculosis in African and Indian children. N Engl J Med 386(10):911–922
Article CAS PubMed PubMed Central Google Scholar
Toussi SS, Pan N, Walters HM, Walsh T (2013) Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-Inhibitors: systematic review of the literature. Clin Infect Dis 57:1318–1330
Article PubMed PubMed Central Google Scholar
Seddon JA, Johnson S, Palmer M, van der Zalm MM, Lopez-Varela E, Hughes J et al (2021) Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment. Expert Rev Respir Med 15:221–237
Article CAS PubMed Google Scholar
Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T (2017) Epidemiology of invasive fungal disease in children. J Pediatric Infect Dis Soc 6:S3–11
Article PubMed PubMed Central Google Scholar
Ramos JT, Francisco L, Daoud Z (2016) Invasive fungal infections in children: similarities and differences with adults. Rev Esp Quimioter 29(Suppl 1):59–65
Galli M, Antinori S, Atzeni F, Meroni L, Riva A, Scirè C et al (2017) Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis. Clin Exp Rhumatol 35(6):1018–1028
Vinicki JP, Pellet SC, Pappalardo C, Cruzat VC, Spinetto MA, Dubinsky D et al (2013) Invasive fungal infections in Argentine patients with systemic lupus erythematosus. Lupus 22(9):892–898
Article CAS PubMed Google Scholar
Kim HJ, Park YJ, Kim WU, Park SH, Cho CS (2009) Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea. Lupus 18(7):661–666
Tragiannidis A, Kyriakidis I, Zündorf I, Groll AH (2017) Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors. Mycoses 60:222–229
Article CAS PubMed Google Scholar
Kyriakidis I, Tragiannidis A, Zündorf I, Groll AH (2017) Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. Mycoses 60:493–507
Article CAS PubMed Google Scholar
Ferreras-Antolín L, Irwin A, Atra A, Chapelle F, Drysdale SB, Emonts M et al (2022) Pediatric antifungal prescribing patterns identify significant opportunities to rationalize antifungal use in children. Pediatr Infect Dis J 41(3):E69–74
Ferreras-Antolín L, Sharland M, Warris A (2019) Management of invasive fungal disease in neonates and children. Pediatr Infect Dis J 38(6 S Suppl 1):S2–6
Martín Pedraz L, Carazo Gallego B, Moreno PD (2021) Clinical-epidemiological characteristics of Pneumocystis jirovecii pneumonia in a tertiary hospital in Spain. An Pediatr (Barc) 95:4–10
Comments (0)